Meeting
2021 ASCO Quality Care Symposium
Evaluation of drug cost avoidance resulting from conduct of cancer clinical trials in a community-based oncology practice.
Authors
Amit Sanyal
SSM Health Cancer Care, Madison, WI
Amit Sanyal, James M. Heun, Brittany Glynn, Ryan Porter, Daniel Wellner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities; Patient Experience
Track
Cost, Value, and Policy,Technology and Innovation in Quality of Care,Health Care Access, Equity, and Disparities,Patient Experience,Quality, Safety, and Implementation Science
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 39, 2021 (suppl 28; abstr 66)
DOI
10.1200/JCO.2020.39.28_suppl.66
Abstract #
66
Poster Bd #
C5
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Commercial health plan spending on oncology drugs approved via the accelerated approval pathway and later withdrawn from the market.
First Author: Tejas Patel
Poster
2015 ASCO Annual Meeting
Trends in the costs and utilization of targeted cancer therapies for the privately insured non-elderly: 2001-2011.
First Author: Fabrice Smieliauskas
Poster
2015 Genitourinary Cancers Symposium
Evaluation of the economic impact of the CCP assay in localized prostate cancer.
First Author: E. David Crawford
Poster
2024 ASCO Annual Meeting
Mind the gap: Estimating the opportunity lost due to the gap between FDA and EMA cancer drug approvals.
First Author: Samantha Gage